Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    15947928 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Opioid Growth Factor (OGF) and Gemcitabine: Novel Treatment for Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: Gemcitabine;   Biological: Opioid Growth Factor (OGF)

Indicates status has not been verified in more than two years